EFNB3 and central nervous system cancer: First, miR‐204 targets EphB2 in glioma cells (Ying et al., 2014) and regulates retinal axon guidance through Efnb3 (ephrin ligand) and EphB2 (receptor) during eye development in medaka (Conte et al., 2014).